As of Nov 13, 2026. At least 3 observations, ranked by Alpha IQ over 63 trading days. 1,586 eligible records before the optional luck filter.
Link an account to see your stake.
#1 Daron Evans
13 buys · 0 sales · 63 trading days
Alpha IQ90.2
Why this rank?
12 of 13 worked
Luck not ruled out
Luck could explain this record.
This rank comes from 13 purchases and 0 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
13 trade dates · 6 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought RZLTMar 26, 2025$57,700
Stock +52.2%; recorded comparison +33.8%; outcome in the trade's direction +18.4%.
2 reported lines and filing sources
Mar 26, 2025 · $28,800 · Form 4Stock +52.2% versus the recorded factor comparison +33.8%.
Mar 26, 2025 · $28,900 · Form 4Stock +52.2% versus the recorded factor comparison +33.8%.
Bought RZLTMay 29, 2024$1,579
Stock +18.1%; recorded comparison +11.5%; outcome in the trade's direction +6.6%.
1 reported line and filing sources
May 29, 2024 · $1,579 · Form 4Stock +18.1% versus the recorded factor comparison +11.5%.
Bought RZLTMar 15, 2024$33,830
Stock +104.2%; recorded comparison +35.1%; outcome in the trade's direction +69.2%.
1 reported line and filing sources
Mar 15, 2024 · $33,830 · Form 4Stock +104.2% versus the recorded factor comparison +35.1%.
Bought RZLTFeb 16, 2024$54,411
Stock +93.8%; recorded comparison +28.2%; outcome in the trade's direction +65.6%.
1 reported line and filing sources
Feb 16, 2024 · $54,411 · Form 4Stock +93.8% versus the recorded factor comparison +28.2%.
Bought RZLTJun 24, 2025$20,250
Stock +100.9%; recorded comparison +66.0%; outcome in the trade's direction +35.0%.
1 reported line and filing sources
Jun 24, 2025 · $20,250 · Form 4Stock +100.9% versus the recorded factor comparison +66.0%.
Bought RZLTDec 9, 2025$53,167
Stock -69.3%; recorded comparison -108.7%; outcome in the trade's direction +39.4%.
1 reported line and filing sources
Dec 9, 2025 · $53,167 · Form 4Stock -69.3% versus the recorded factor comparison -108.7%.
Bought RZLTMay 23, 2024$165
Stock +29.8%; recorded comparison +13.7%; outcome in the trade's direction +16.1%.
1 reported line and filing sources
May 23, 2024 · $165 · Form 4Stock +29.8% versus the recorded factor comparison +13.7%.
Bought RZLTDec 12, 2024$41,400
Stock -27.4%; recorded comparison -35.1%; outcome in the trade's direction +7.7%.
1 reported line and filing sources
Dec 12, 2024 · $41,400 · Form 4Stock -27.4% versus the recorded factor comparison -35.1%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001411726. Profile company CIK 0001509261. Rezolute, Inc.
Recorded role: CFO · RZLT.
13 obs. Confidence 80; 63-day hit rate 92.3%. Confidence measures the sample, not a probability of future success.
Luck reference: 12 of 13 represented trade dates; upper tail 1.481e-4; corrected within the horizon 1.114e-1, across 24734 person/horizon comparisons 9.812e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 6 windows, with 6 wins and upper tail 4.258e-3.
This rank comes from 13 purchases and 0 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
14 trade dates · 2 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought AIRSMar 23, 2026$145,500
Stock +44.9%; recorded comparison +16.0%; outcome in the trade's direction +29.0%.
1 reported line and filing sources
Mar 23, 2026 · $145,500 · Form 4Stock +44.9% versus the recorded factor comparison +16.0%.
Bought AIRSMar 20, 2026$110,800
Stock +65.5%; recorded comparison +26.5%; outcome in the trade's direction +39.0%.
1 reported line and filing sources
Mar 20, 2026 · $110,800 · Form 4Stock +65.5% versus the recorded factor comparison +26.5%.
Bought AIRSMar 19, 2026$205,133
Stock +78.9%; recorded comparison +36.0%; outcome in the trade's direction +42.9%.
1 reported line and filing sources
Mar 19, 2026 · $205,133 · Form 4Stock +78.9% versus the recorded factor comparison +36.0%.
Bought AIRSMar 17, 2026$212,480
Stock +72.4%; recorded comparison +37.7%; outcome in the trade's direction +34.7%.
1 reported line and filing sources
Mar 17, 2026 · $212,480 · Form 4Stock +72.4% versus the recorded factor comparison +37.7%.
Bought AIRSMar 16, 2026$257,211
Stock +81.1%; recorded comparison +45.4%; outcome in the trade's direction +35.7%.
1 reported line and filing sources
Mar 16, 2026 · $257,211 · Form 4Stock +81.1% versus the recorded factor comparison +45.4%.
Bought AIRSMar 11, 2026$189,200
Stock +119.9%; recorded comparison +46.5%; outcome in the trade's direction +73.5%.
1 reported line and filing sources
Mar 11, 2026 · $189,200 · Form 4Stock +119.9% versus the recorded factor comparison +46.5%.
Bought AIRSMar 6, 2026$91,200
Stock +144.2%; recorded comparison +60.0%; outcome in the trade's direction +84.2%.
1 reported line and filing sources
Mar 6, 2026 · $91,200 · Form 4Stock +144.2% versus the recorded factor comparison +60.0%.
Bought AIRSMar 3, 2026$192,900
Stock +181.7%; recorded comparison +86.7%; outcome in the trade's direction +95.1%.
2 reported lines and filing sources
Mar 4, 2026 · $56,100 · Form 4Stock +181.7% versus the recorded factor comparison +86.7%.
Mar 3, 2026 · $136,800 · Form 4Stock +181.7% versus the recorded factor comparison +86.7%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0002042077. Profile company CIK 0001274737. EXAGEN INC.
13 obs. Confidence 80; 63-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 23.2):
Past calls: 57% directionally correct over 3 months (adjusted toward 50% peer prior; 64% observed; recency-weighted sample 23.2)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 13 of 13 represented trade dates; upper tail 7.301e-6; corrected within the horizon 9.787e-3, across 24734 person/horizon comparisons 1.673e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 2 wins and upper tail 1.621e-1.
This rank comes from 14 purchases and 0 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
16 trade dates · 4 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought PODCMar 27, 2025$19,254
Stock +57.1%; recorded comparison +10.4%; outcome in the trade's direction +46.7%.
3 reported lines and filing sources
Mar 27, 2025 · $4,832 · Form 4Stock +57.1% versus SPY +10.4%.
Mar 31, 2025 · $7,852 · Form 4Stock +57.1% versus SPY +10.4%.
Mar 28, 2025 · $6,570 · Form 4Stock +57.1% versus SPY +10.4%.
Bought PODCMar 18, 2025$12,040
Stock +14.7%; recorded comparison +5.3%; outcome in the trade's direction +9.3%.
1 reported line and filing sources
Mar 18, 2025 · $12,040 · Form 4Stock +14.7% versus SPY +5.3%.
Bought PODCAug 22, 2025$16,539
Stock +59.1%; recorded comparison +3.7%; outcome in the trade's direction +55.5%.
1 reported line and filing sources
Aug 22, 2025 · $16,539 · Form 4Stock +59.1% versus SPY +3.7%.
Bought PODCAug 21, 2025$8,493
Stock +81.5%; recorded comparison +2.6%; outcome in the trade's direction +79.0%.
1 reported line and filing sources
Aug 21, 2025 · $8,493 · Form 4Stock +81.5% versus SPY +2.6%.
Bought PODCSep 4, 2025$15,800
Stock +37.6%; recorded comparison +5.7%; outcome in the trade's direction +31.9%.
1 reported line and filing sources
Sep 4, 2025 · $15,800 · Form 4Stock +37.6% versus SPY +5.7%.
Bought PODCNov 19, 2025$24,200
Stock +11.4%; recorded comparison +5.2%; outcome in the trade's direction +6.3%.
1 reported line and filing sources
Nov 19, 2025 · $24,200 · Form 4Stock +11.4% versus SPY +5.2%.
Bought PODCNov 14, 2025$23,112
Stock +10.0%; recorded comparison +2.8%; outcome in the trade's direction +7.2%.
1 reported line and filing sources
Nov 14, 2025 · $23,112 · Form 4Stock +10.0% versus SPY +2.8%.
Bought PODCDec 16, 2025$12,688
Stock +5.8%; recorded comparison -3.1%; outcome in the trade's direction +8.9%.
1 reported line and filing sources
Dec 16, 2025 · $12,688 · Form 4Stock +5.8% versus SPY -3.1%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001022711. Profile company CIK 0001940177. PodcastOne, Inc.
14 obs. Confidence 83; 63-day hit rate 92.9%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 16.2):
Past calls: 62% directionally correct over 3 months (adjusted toward 50% peer prior; 79% observed; recency-weighted sample 16.2)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 13 of 14 represented trade dates; upper tail 6.400e-5; corrected within the horizon 6.735e-2, across 24734 person/horizon comparisons 6.088e-2. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 4 wins and upper tail 2.627e-2.
This rank comes from 2 purchases and 10 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
12 trade dates · 4 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Sold TFSLDec 19, 2023$298,092
Stock -16.0%; recorded comparison -4.4%; outcome in the trade's direction +11.7%.
1 reported line and filing sources
Dec 19, 2023 · $298,092 · Form 4Stock -16.0% versus the recorded factor comparison -4.4%.
Sold TFSLFeb 26, 2025$131,100
Stock +1.8%; recorded comparison +3.9%; outcome in the trade's direction +2.0%.
1 reported line and filing sources
Feb 26, 2025 · $131,100 · Form 4Stock +1.8% versus the recorded factor comparison +3.9%.
Sold TFSLJan 3, 2024$214,170
Stock -13.5%; recorded comparison +2.0%; outcome in the trade's direction +15.5%.
1 reported line and filing sources
Jan 3, 2024 · $214,170 · Form 4Stock -13.5% versus the recorded factor comparison +2.0%.
Sold TFSLDec 22, 2023$149,367
Stock -17.4%; recorded comparison -3.9%; outcome in the trade's direction +13.5%.
1 reported line and filing sources
Dec 22, 2023 · $149,367 · Form 4Stock -17.4% versus the recorded factor comparison -3.9%.
Sold TFSLFeb 13, 2024$135,469
Stock +3.2%; recorded comparison +7.4%; outcome in the trade's direction +4.2%.
1 reported line and filing sources
Feb 13, 2024 · $135,469 · Form 4Stock +3.2% versus the recorded factor comparison +7.4%.
Sold TFSLJan 11, 2024$207,356
Stock -13.7%; recorded comparison +0.5%; outcome in the trade's direction +14.3%.
1 reported line and filing sources
Jan 11, 2024 · $207,356 · Form 4Stock -13.7% versus the recorded factor comparison +0.5%.
Sold TFSLSep 11, 2025$52,143
Stock +2.8%; recorded comparison +0.0%; outcome in the trade's direction -2.8%.
1 reported line and filing sources
Sep 11, 2025 · $52,143 · Form 4Stock +2.8% versus the recorded factor comparison +0.0%.
Sold TFSLJan 9, 2024$211,769
Stock -14.1%; recorded comparison +1.7%; outcome in the trade's direction +15.8%.
1 reported line and filing sources
Jan 9, 2024 · $211,769 · Form 4Stock -14.1% versus the recorded factor comparison +1.7%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001936663. Profile company CIK 0001381668. TFS Financial CORP
12 obs. Confidence 78; 63-day hit rate 91.7%. Confidence measures the sample, not a probability of future success.
Luck reference: 11 of 12 represented trade dates; upper tail 6.125e-3; corrected within the horizon 6.319e-1, across 24734 person/horizon comparisons 6.339e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 3 wins and upper tail 3.463e-1.
This rank comes from 1 purchases and 11 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
12 trade dates · 2 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Sold DVJan 16, 2024$32,679
Stock -23.3%; recorded comparison -2.4%; outcome in the trade's direction +20.9%.
1 reported line and filing sources
Jan 16, 2024 · $32,679 · Form 4Stock -23.3% versus the recorded factor comparison -2.4%.
Sold DVApr 2, 2024$29,745
Stock -39.5%; recorded comparison +2.5%; outcome in the trade's direction +42.1%.
1 reported line and filing sources
Apr 2, 2024 · $29,745 · Form 4Stock -39.5% versus the recorded factor comparison +2.5%.
Sold DVApr 16, 2024$27,765
Stock -33.6%; recorded comparison +12.7%; outcome in the trade's direction +46.3%.
1 reported line and filing sources
Apr 16, 2024 · $27,765 · Form 4Stock -33.6% versus the recorded factor comparison +12.7%.
Sold DVDec 12, 2023$25,125
Stock -4.9%; recorded comparison +9.1%; outcome in the trade's direction +14.0%.
1 reported line and filing sources
Dec 12, 2023 · $25,125 · Form 4Stock -4.9% versus the recorded factor comparison +9.1%.
Sold DVMay 7, 2024$27,900
Stock -0.2%; recorded comparison +4.7%; outcome in the trade's direction +4.9%.
1 reported line and filing sources
May 7, 2024 · $27,900 · Form 4Stock -0.2% versus the recorded factor comparison +4.7%.
Sold DVMar 19, 2024$30,222
Stock -42.0%; recorded comparison +1.0%; outcome in the trade's direction +43.0%.
1 reported line and filing sources
Mar 19, 2024 · $30,222 · Form 4Stock -42.0% versus the recorded factor comparison +1.0%.
Sold DVFeb 20, 2024$37,503
Stock -55.2%; recorded comparison +9.4%; outcome in the trade's direction +64.6%.
1 reported line and filing sources
Feb 20, 2024 · $37,503 · Form 4Stock -55.2% versus the recorded factor comparison +9.4%.
Sold DVDec 26, 2023$28,103
Stock -9.6%; recorded comparison +7.4%; outcome in the trade's direction +17.0%.
1 reported line and filing sources
Dec 26, 2023 · $28,103 · Form 4Stock -9.6% versus the recorded factor comparison +7.4%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 1853942. Profile company CIK ticker:DV. DV
12 obs. Confidence 78; 63-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 12 of 12 represented trade dates; upper tail 7.317e-4; corrected within the horizon 2.053e-1, across 24734 person/horizon comparisons 2.104e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 2 wins and upper tail 3.175e-1.
This rank comes from 21 purchases and 0 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
24 trade dates · 4 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought GLSIJan 10, 2025$31,275
Stock -24.3%; recorded comparison -24.5%; outcome in the trade's direction +0.2%.
1 reported line and filing sources
Jan 10, 2025 · $31,275 · Form 4Stock -24.3% versus the recorded factor comparison -24.5%.
Bought GLSIJan 6, 2025$39,391
Stock -30.2%; recorded comparison -33.9%; outcome in the trade's direction +3.7%.
2 reported lines and filing sources
Jan 6, 2025 · $14,641 · Form 4Stock -30.2% versus the recorded factor comparison -33.9%.
Jan 7, 2025 · $24,750 · Form 4Stock -30.2% versus the recorded factor comparison -33.9%.
Bought GLSIJan 3, 2025$44,030
Stock -31.7%; recorded comparison -31.5%; outcome in the trade's direction -0.2%.
1 reported line and filing sources
Jan 3, 2025 · $44,030 · Form 4Stock -31.7% versus the recorded factor comparison -31.5%.
Bought GLSIJan 2, 2025$23,940
Stock -30.8%; recorded comparison -41.7%; outcome in the trade's direction +10.9%.
1 reported line and filing sources
Jan 2, 2025 · $23,940 · Form 4Stock -30.8% versus the recorded factor comparison -41.7%.
Bought GLSIDec 31, 2024$27,264
Stock -25.5%; recorded comparison -37.0%; outcome in the trade's direction +11.5%.
1 reported line and filing sources
Dec 31, 2024 · $27,264 · Form 4Stock -25.5% versus the recorded factor comparison -37.0%.
Bought GLSIDec 30, 2024$35,584
Stock -24.8%; recorded comparison -33.9%; outcome in the trade's direction +9.1%.
1 reported line and filing sources
Dec 30, 2024 · $35,584 · Form 4Stock -24.8% versus the recorded factor comparison -33.9%.
Bought GLSIApr 25, 2025$35,568
Stock +8.6%; recorded comparison +27.7%; outcome in the trade's direction -19.1%.
1 reported line and filing sources
Apr 25, 2025 · $35,568 · Form 4Stock +8.6% versus the recorded factor comparison +27.7%.
Bought GLSIApr 17, 2025$48,492
Stock +19.3%; recorded comparison +50.9%; outcome in the trade's direction -31.6%.
1 reported line and filing sources
Apr 17, 2025 · $48,492 · Form 4Stock +19.3% versus the recorded factor comparison +50.9%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001806920. Profile company CIK 0001799788. Greenwich LifeSciences, Inc.
Recorded role: CEO · GLSI.
21 obs. Confidence 93; 63-day hit rate 76.2%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 17.2):
Past calls: 51% directionally correct over 3 months (adjusted toward 50% peer prior; 52% observed; recency-weighted sample 17.2)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 16 of 21 represented trade dates; upper tail 9.083e-4; corrected within the horizon 2.276e-1, across 24734 person/horizon comparisons 2.442e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 3 wins and upper tail 1.822e-1.
This rank comes from 14 purchases and 0 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
16 trade dates · 1 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought CALCJul 22, 2025$5,663
Stock -25.5%; recorded comparison +5.8%; outcome in the trade's direction -31.3%.
1 reported line and filing sources
Jul 22, 2025 · $5,663 · Form 4Stock -25.5% versus SPY +5.8%.
Bought CALCJul 21, 2025$5,055
Stock -15.6%; recorded comparison +6.7%; outcome in the trade's direction -22.4%.
1 reported line and filing sources
Jul 21, 2025 · $5,055 · Form 4Stock -15.6% versus SPY +6.7%.
Bought CALCJul 18, 2025$5,760
Stock +8.0%; recorded comparison +5.3%; outcome in the trade's direction +2.7%.
1 reported line and filing sources
Jul 18, 2025 · $5,760 · Form 4Stock +8.0% versus SPY +5.3%.
Bought CALCJul 14, 2025$15,810
Stock +48.7%; recorded comparison +6.1%; outcome in the trade's direction +42.7%.
1 reported line and filing sources
Jul 14, 2025 · $15,810 · Form 4Stock +48.7% versus SPY +6.1%.
Bought CALCJul 9, 2025$8,024
Stock +96.7%; recorded comparison +7.6%; outcome in the trade's direction +89.1%.
1 reported line and filing sources
Jul 9, 2025 · $8,024 · Form 4Stock +96.7% versus SPY +7.6%.
Bought CALCAug 21, 2025$9,797
Stock +17.9%; recorded comparison +2.6%; outcome in the trade's direction +15.3%.
1 reported line and filing sources
Aug 21, 2025 · $9,797 · Form 4Stock +17.9% versus SPY +2.6%.
Bought CALCAug 19, 2025$8,230
Stock +13.1%; recorded comparison +4.3%; outcome in the trade's direction +8.9%.
2 reported lines and filing sources
Aug 19, 2025 · $2,790 · Form 4Stock +13.1% versus SPY +4.3%.
Aug 20, 2025 · $5,440 · Form 4Stock +13.1% versus SPY +4.3%.
Bought CALCAug 15, 2025$14,709
Stock +13.1%; recorded comparison +4.0%; outcome in the trade's direction +9.1%.
1 reported line and filing sources
Aug 15, 2025 · $14,709 · Form 4Stock +13.1% versus SPY +4.0%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001576244. Profile company CIK 0001534133. CalciMedica, Inc.
Recorded role: Chief Officer · CALC.
14 obs. Confidence 83; 63-day hit rate 85.7%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 11.5):
Past calls: 56% directionally correct over 3 months (adjusted toward 50% peer prior; 70% observed; recency-weighted sample 11.5)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 12 of 14 represented trade dates; upper tail 6.529e-4; corrected within the horizon 2.053e-1, across 24734 person/horizon comparisons 2.009e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 1 windows, with 1 wins and upper tail 4.026e-1.
This rank comes from 54 purchases and 9 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
98 trade dates · 7 nonoverlapping windows · 6 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Bought HROWNov 15, 2023$200,735
Stock +33.6%; recorded comparison +45.6%; outcome in the trade's direction -12.0%.
1 reported line and filing sources
Nov 15, 2023 · $200,735 · Form 4Stock +33.6% versus the recorded factor comparison +45.6%.
Bought CDXSApr 30, 2025$57,660
Stock +12.7%; recorded comparison +16.8%; outcome in the trade's direction -4.1%.
1 reported line and filing sources
Apr 30, 2025 · $57,660 · Form 4Stock +12.7% versus the recorded factor comparison +16.8%.
Bought HROWMar 28, 2024$641,000
Stock +57.9%; recorded comparison +12.6%; outcome in the trade's direction +45.3%.
1 reported line and filing sources
Mar 28, 2024 · $641,000 · Form 4Stock +57.9% versus the recorded factor comparison +12.6%.
Bought HROWApr 23, 2024$120,547
Stock +135.9%; recorded comparison +80.4%; outcome in the trade's direction +55.5%.
1 reported line and filing sources
Apr 23, 2024 · $120,547 · Form 4Stock +135.9% versus the recorded factor comparison +80.4%.
Bought HROWApr 19, 2024$310,391
Stock +141.9%; recorded comparison +82.2%; outcome in the trade's direction +59.7%.
1 reported line and filing sources
Apr 19, 2024 · $310,391 · Form 4Stock +141.9% versus the recorded factor comparison +82.2%.
Bought CDXSJun 12, 2025$225,000
Stock +11.2%; recorded comparison +20.2%; outcome in the trade's direction -9.0%.
1 reported line and filing sources
Jun 12, 2025 · $225,000 · Form 4Stock +11.2% versus the recorded factor comparison +20.2%.
Bought CDXSMar 20, 2025$236,284
Stock -18.6%; recorded comparison +15.6%; outcome in the trade's direction -34.1%.
2 reported lines and filing sources
Mar 20, 2025 · $18 · Form 4Stock -18.6% versus the recorded factor comparison +15.6%.
Mar 21, 2025 · $236,266 · Form 4Stock -18.6% versus the recorded factor comparison +15.6%.
Bought CDXSMar 13, 2025$216,155
Stock -19.8%; recorded comparison +5.7%; outcome in the trade's direction -25.5%.
1 reported line and filing sources
Mar 13, 2025 · $216,155 · Form 4Stock -19.8% versus the recorded factor comparison +5.7%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001595855. Profile company CIK 0001417663. SANUWAVE Health, Inc.
Recorded role: 10% Owner · SNVW.
63 obs. Confidence 100; 63-day hit rate 63.5%. Confidence measures the sample, not a probability of future success.
Separate past-calls measure (3 months · sample 121.3):
Past calls: 58% directionally correct over 3 months (adjusted toward 50% peer prior; 59% observed; recency-weighted sample 121.3)
Descriptive statistic of past trades, not a prediction
How to read these past calls · As of 2026-11-13
Bullish calls are correct after outperformance; bearish calls are correct after underperformance, relative to SPY. Only directional buy and sell signals are graded. Gifts, grants and tax withholding are excluded. Recent outcomes receive more weight, with a half-life of 252 trading days. The peer prior contributes 24 equivalent outcomes. The weighted sample is not a count of trades.
Luck reference: 39 of 61 represented trade dates; upper tail 6.029e-4; corrected within the horizon 2.053e-1, across 24734 person/horizon comparisons 1.988e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 7 windows, with 3 wins and upper tail 6.831e-1.
This rank comes from 1 purchases and 10 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
12 trade dates · 2 nonoverlapping windows · 2 stocks. Shared stock moves and overlapping windows are not separate tests of skill.
Sold BRBRFeb 24, 2025$2,159,362
Stock -15.6%; recorded comparison +7.6%; outcome in the trade's direction +23.1%.
3 reported lines and filing sources
Feb 24, 2025 · $1,039,217 · Form 4Stock -15.6% versus the recorded factor comparison +7.6%.
Feb 25, 2025 · $1,063,442 · Form 4Stock -15.6% versus the recorded factor comparison +7.6%.
Feb 24, 2025 · $56,703 · Form 4Stock -15.6% versus the recorded factor comparison +7.6%.
Sold BRBRFeb 21, 2025$1,102,001
Stock -15.4%; recorded comparison +4.1%; outcome in the trade's direction +19.4%.
3 reported lines and filing sources
Feb 21, 2025 · $719,396 · Form 4Stock -15.4% versus the recorded factor comparison +4.1%.
Feb 21, 2025 · $367,636 · Form 4Stock -15.4% versus the recorded factor comparison +4.1%.
Feb 21, 2025 · $14,968 · Form 4Stock -15.4% versus the recorded factor comparison +4.1%.
Sold BRBRFeb 20, 2025$3,494,520
Stock -16.9%; recorded comparison +2.2%; outcome in the trade's direction +19.1%.
3 reported lines and filing sources
Feb 20, 2025 · $2,483,737 · Form 4Stock -16.9% versus the recorded factor comparison +2.2%.
Feb 20, 2025 · $925,776 · Form 4Stock -16.9% versus the recorded factor comparison +2.2%.
Feb 20, 2025 · $85,008 · Form 4Stock -16.9% versus the recorded factor comparison +2.2%.
Sold BRBRFeb 19, 2025$3,365,576
Stock -16.2%; recorded comparison -0.5%; outcome in the trade's direction +15.8%.
1 reported line and filing sources
Feb 19, 2025 · $3,365,576 · Form 4Stock -16.2% versus the recorded factor comparison -0.5%.
Sold BRBRFeb 18, 2025$3,423,486
Stock -15.6%; recorded comparison +2.2%; outcome in the trade's direction +17.8%.
2 reported lines and filing sources
Feb 18, 2025 · $2,708,747 · Form 4Stock -15.6% versus the recorded factor comparison +2.2%.
Feb 18, 2025 · $714,739 · Form 4Stock -15.6% versus the recorded factor comparison +2.2%.
Sold BRBRFeb 14, 2025$6,091,113
Stock -13.9%; recorded comparison +1.2%; outcome in the trade's direction +15.0%.
2 reported lines and filing sources
Feb 14, 2025 · $5,904,969 · Form 4Stock -13.9% versus the recorded factor comparison +1.2%.
Feb 14, 2025 · $186,144 · Form 4Stock -13.9% versus the recorded factor comparison +1.2%.
Sold BRBRFeb 13, 2025$3,738,790
Stock -14.1%; recorded comparison +1.3%; outcome in the trade's direction +15.3%.
1 reported line and filing sources
Feb 13, 2025 · $3,738,790 · Form 4Stock -14.1% versus the recorded factor comparison +1.3%.
Sold BRBRFeb 12, 2025$2,188,320
Stock -17.1%; recorded comparison -2.3%; outcome in the trade's direction +14.8%.
1 reported line and filing sources
Feb 12, 2025 · $2,188,320 · Form 4Stock -17.1% versus the recorded factor comparison -2.3%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001540021. Profile company CIK 0001772016. BELLRING BRANDS, INC.
Recorded role: CEO · BRBR.
11 obs. Confidence 75; 63-day hit rate 100.0%. Confidence measures the sample, not a probability of future success.
Luck reference: 11 of 11 represented trade dates; upper tail 1.299e-3; corrected within the horizon 2.989e-1, across 24734 person/horizon comparisons 3.088e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 2 windows, with 2 wins and upper tail 2.268e-1.
This rank comes from 11 purchases and 0 sales, measured over 63 trading days after disclosure. The score describes these past outcomes; it does not establish forecasting skill.
○ Buy · ◆ Sale · solid line: mean. Right of zero means a purchase beat its recorded comparison, or a sale lagged it.
11 trade dates · 4 nonoverlapping windows · 1 stock. One stock's trend can produce several wins.
Bought TKOFeb 10, 2025$643,656
Stock -8.2%; recorded comparison -20.9%; outcome in the trade's direction +12.8%.
1 reported line and filing sources
Feb 10, 2025 · $643,656 · Form 4Stock -8.2% versus the recorded factor comparison -20.9%.
Bought TKOFeb 5, 2025$727,444
Stock -4.0%; recorded comparison -13.1%; outcome in the trade's direction +9.1%.
1 reported line and filing sources
Feb 5, 2025 · $727,444 · Form 4Stock -4.0% versus the recorded factor comparison -13.1%.
Bought TKONov 14, 2023$999,974
Stock +8.9%; recorded comparison +6.7%; outcome in the trade's direction +2.2%.
1 reported line and filing sources
Nov 14, 2023 · $999,974 · Form 4Stock +8.9% versus the recorded factor comparison +6.7%.
Bought TKOApr 9, 2024$146,240,760
Stock +13.7%; recorded comparison +6.3%; outcome in the trade's direction +7.4%.
1 reported line and filing sources
Apr 9, 2024 · $146,240,760 · Form 4Stock +13.7% versus the recorded factor comparison +6.3%.
Bought TKODec 11, 2024$4,270,126
Stock +5.6%; recorded comparison -7.8%; outcome in the trade's direction +13.4%.
1 reported line and filing sources
Dec 11, 2024 · $4,270,126 · Form 4Stock +5.6% versus the recorded factor comparison -7.8%.
Bought TKOJan 31, 2025$3,654,514
Stock +6.5%; recorded comparison -12.0%; outcome in the trade's direction +18.5%.
1 reported line and filing sources
Jan 31, 2025 · $3,654,514 · Form 4Stock +6.5% versus the recorded factor comparison -12.0%.
Bought TKOJan 23, 2025$1,829,891
Stock +4.5%; recorded comparison -18.0%; outcome in the trade's direction +22.6%.
1 reported line and filing sources
Jan 23, 2025 · $1,829,891 · Form 4Stock +4.5% versus the recorded factor comparison -18.0%.
Bought TKOJan 17, 2025$8,738,971
Stock +5.6%; recorded comparison -19.4%; outcome in the trade's direction +25.1%.
1 reported line and filing sources
Jan 17, 2025 · $8,738,971 · Form 4Stock +5.6% versus the recorded factor comparison -19.4%.
Technical details
Stored snapshot 2026-11-13; calculation insider-iq-person-score.v3. Each mark averages only the filed lines sharing the production score's decision or entry window. Its stored score and counts are checked against these inputs before the record is drawn.
Insider CIK 0001320234. Profile company CIK 0001973266. TKO Group Holdings, Inc.
Recorded role: Chief Executive Officer · TKO.
11 obs. Confidence 75; 63-day hit rate 90.9%. Confidence measures the sample, not a probability of future success.
Luck reference: 10 of 11 represented trade dates; upper tail 7.802e-4; corrected within the horizon 2.053e-1, across 24734 person/horizon comparisons 2.169e-1. Overlapping windows, shared stocks and a reference estimated from the same history limit this interpretation. The nonoverlapping sensitivity keeps 4 windows, with 3 wins and upper tail 1.822e-1.
One entry per filing selected from the current 90-day scored feed. Derivatives and known open-market trades below $10,000 are excluded from conviction scoring. These are reported transactions, not live trades. A trade score and an insider's historical Alpha IQ measure different things.